세계의 혁신 의료 시장 : 치료 유형별, 용도별, 투여 경로별, 최종사용자별, 지역별
Innovative Medicine Market, By Therapy Type, By Application, By Route of Administration, By End User, By Region
상품코드
:
1747269
리서치사
:
Coherent Market Insights
발행일
:
2025년 05월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 혁신 의료 시장은 2025년에 2,542억 1,000만 달러, 2032년에는 4,272억 달러에 이르고, 2025-2032년 연평균 복합 성장률(CAGR)은 7.7%로 성장할 전망입니다.
| 보고서 범위 |
보고서 상세 |
| 기준 연도 |
2024 |
2025년 시장 규모 |
2,542억 1,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
7.70% |
2032년 가치 예측 |
4,272억 달러 |
세계 혁신 의료 시장은 만성질환의 확산, 맞춤형 의료에 대한 수요 증가, 연구개발(R&D)에 대한 관심 증가 등을 배경으로 최근 괄목할 만한 성장세를 보이고 있습니다. 혁신 의약품은 특수 의약품 또는 바이오 의약품으로 알려져 있으며, 다양한 질병에 대해 새롭고 개선된 치료 옵션을 제공하는 첨단 치료법입니다. 이러한 의약품은 최첨단 기술을 통해 개발되며, 특정 분자 경로, 유전자 마커 또는 질병 메커니즘을 표적으로 삼도록 설계되어 있습니다. 시장은 암, 면역학, 신경학, 희귀질환 등 다양한 치료 분야를 아우르고 있습니다. 유전체학, 단백질체학, 바이오마커 연구의 발전에 따라 제약사들이 미충족 의료 수요에 대응하고 환자의 예후를 개선하기 위한 새로운 치료법 개발에 지속적으로 투자함에 따라 혁신 의료 시장은 향후 몇 년 동안 크게 성장할 것으로 예측됩니다.
시장 역학
세계 혁신 의료 시장은 성장 궤도를 형성하는 몇 가지 중요한 요인의 영향을 받고 있습니다. 주요 촉진요인 중 하나는 암, 당뇨병, 심혈관 질환과 같은 만성 질환의 유병률 증가이며, 이러한 질환은 첨단 치료 옵션에 대한 높은 수요를 창출하고 있습니다. 또한, 노인들은 혁신적인 치료가 필요한 만성 질환에 걸리기 쉽기 때문에 전 세계적으로 고령화가 진행되면서 시장 성장에 기여하고 있습니다. 또한, 의료비 지출 증가와 프리미엄 의료 솔루션에 대한 환자들의 지불 의향이 시장 확대를 더욱 촉진하고 있습니다. 그러나 신흥국 시장의 경우 혁신적 의약품의 개발 및 제조 비용이 높고, 환자 접근성이 제한적이라는 시장 성장 억제요인도 존재합니다. 또한, 엄격한 규제 요건과 긴 승인 절차로 인해 제약사들은 어려움을 겪고 있으며, 이는 신제품 시장 진입을 지연시킬 수 있습니다. 이러한 시장 성장 억제요인에도 불구하고, 혁신 의료 시장에는 큰 성장 기회가 있습니다. 환자 개개인의 특성에 맞는 치료를 제공하는 개인 맞춤형 의료에 대한 관심이 높아지면서 시장 기업들에게 새로운 길을 열어주고 있습니다. 또한, 원격 의료 및 원격 모니터링과 같은 디지털 헬스 기술의 채택이 증가함에 따라 더 나은 환자 관리가 가능해져 혁신적인 치료법 제공이 강화될 것입니다. 제약사, R&D 기관, 기술 기업간의 제휴는 혁신적인 의료 솔루션 개발 기회를 가져와 혁신 의료 시장의 성장을 가속할 것입니다.
본 조사의 주요 특징
- 세계의 혁신 의료 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 혁신 의료 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 혁신 의료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 혁신 의료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER 분석
- 인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 혁신 의료 시장 : 치료 유형별, 2020-2032년
- 면역치료
- 세포치료
- 유전자치료
- 조직공학
- 소분자 요법
- 생물학적 요법
- RNA 기반 치료법
- 전구세포 요법
- 펩티드 기반 치료법
- 마이크로바이옴 요법
- 안티센스 올리고뉴클레오티드 요법
- CRISPR 기반 치료법
- mRNA 기반 백신
- 단일클론항체
제5장 세계의 혁신 의료 시장 : 용도별, 2020-2032년
- 종양학
- 신경학
- 심장병학
- 안과
- 피부과
- 근골격계 장애
- 면역학 및 염증
- 유전성 질환
- 감염증
- 대사장애
- 혈액학
- 희귀질환
- 소화기내과
- 기타(재생의료 등)
제6장 세계의 혁신 의료 시장 : 투여 경로별, 2020-2032년
제7장 세계의 혁신 의료 시장 : 최종사용자별, 2020-2032년
- 병원 및 진료소
- 학술연구기관
- 전문센터
- 외래수술센터(ASC)
- 정부 및 규제기관
- 기타(진단실험실 등)
제8장 세계의 혁신 의료 시장 : 지역별, 2020-2032년
- 북미
- 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- Pfizer Inc
- Roche Holding AG
- Johnson & Johnson
- Novartis AG
- Merck & Co Inc
- Gilead Sciences Inc
- Amgen Inc
- Bristol-Myers Squibb Company
- Sanofi S.A
- AstraZeneca PLC
- Eli Lilly and Company
- AbbVie Inc
- Regeneron Pharmaceuticals Inc
- Takeda Pharmaceutical Company Limited
- Biogen Inc
제10장 애널리스트 추천 사항
- Wheel of Fortune
- 애널리스트의 견해
- COM(Coherent Opportunity Map)
제11장 참고 문헌과 조사 방법
LSH
영문 목차
Global Innovative Medicine Market is estimated to be valued at USD 254.21 Bn in 2025 and is expected to reach USD 427.20 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 254.21 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
7.70% |
2032 Value Projection: |
USD 427.20 Bn |
The global innovative medicine market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases, the rising demand for personalized medicine, and the growing focus on research and development activities. Innovative medicines, also known as specialty drugs or biopharmaceuticals, are advanced medical treatments that offer new and improved therapeutic options for various diseases. These medicines are developed using cutting-edge technologies and are designed to target specific molecular pathways, genetic markers, or disease mechanisms. The market encompasses a wide range of therapeutic areas, including oncology, immunology, neurology, and rare diseases. With the advancements in genomics, proteomics, and biomarker research, the innovative medicine market is poised for substantial growth in the coming years, as pharmaceutical companies continue to invest in the development of novel therapies to address unmet medical needs and improve patient outcomes.
Market Dynamics:
The global innovative medicine market is influenced by several key factors that shape its growth trajectory. One of the primary drivers is the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, which create a high demand for advanced therapeutic options. Additionally, the growing aging population worldwide contributes to the market growth, as older individuals are more susceptible to chronic conditions requiring innovative treatments. Moreover, the rising healthcare expenditure and the willingness of patients to pay for premium medical solutions further fuel the market expansion. However, the market also faces certain restraints, such as the high cost associated with the development and manufacturing of innovative medicines, which can limit their accessibility to patients. Stringent regulatory requirements and lengthy approval processes also pose challenges for pharmaceutical companies, potentially delaying the entry of new products into the market. Despite these restraints, the innovative medicine market presents significant opportunities for growth. The increasing focus on personalized medicine, which tailors treatments to individual patient characteristics, opens up new avenues for market players. Furthermore, the growing adoption of digital health technologies, such as telemedicine and remote monitoring, enables better patient management and enhances the delivery of innovative therapies. Collaborations between pharmaceutical companies, research institutions, and technology firms also present opportunities for the development of groundbreaking medical solutions, driving the future growth of the innovative medicine market.
Key Features of the Study:
- This report provides in-depth analysis of the global innovative medicine market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global innovative medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc, Roche Holding AG, Johnson & Johnson, Novartis AG, Merck & Co Inc, Gilead Sciences Inc, Amgen Inc, Bristol-Myers Squibb Company, Sanofi S.A, AstraZeneca PLC, Eli Lilly and Company, AbbVie Inc, Regeneron Pharmaceuticals Inc, Takeda Pharmaceutical Company Limited, Biogen Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global innovative medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global innovative medicine market.
Market Segmentation
- Therapy Type Insights (Revenue, USD Bn, 2020 - 2032)
- Immunotherapy
- Cell Therapy
- Gene Therapy
- Tissue Engineering
- Small Molecule Therapy
- Biologic Therapy
- RNA-Based Therapy
- Progenitor Cell Therapy
- Peptide-Based Therapy
- Microbiome Therapy
- Antisense Oligonucleotide Therapy
- CRISPR-based Therapy
- mRNA-based Vaccines
- Monoclonal Antibodies
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurology
- Cardiology
- Ophthalmology
- Dermatology
- Musculoskeletal Disorders
- Immunology & Inflammation
- Genetic Disorders
- Infectious Diseases
- Metabolic Disorders
- Hematology
- Rare Diseases
- Gastroenterology
- Others (Regenerative Medicine, etc.)
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Intravenous
- Subcutaneous
- Intramuscular
- Topical
- Inhalation
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals & Clinics
- Academic & Research Institutes
- Specialty Centers
- Ambulatory Surgical Centers
- Government & Regulatory Bodies
- Others (Diagnostic labs, etc.)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc
- Roche Holding AG
- Johnson & Johnson
- Novartis AG
- Merck & Co Inc
- Gilead Sciences Inc
- Amgen Inc
- Bristol-Myers Squibb Company
- Sanofi S.A
- AstraZeneca PLC
- Eli Lilly and Company
- AbbVie Inc
- Regeneron Pharmaceuticals Inc
- Takeda Pharmaceutical Company Limited
- Biogen Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Innovative Medicine Market, By Therapy Type
- Global Innovative Medicine Market, By Application
- Global Innovative Medicine Market, By Route of Administration
- Global Innovative Medicine Market, By End User
- Global Innovative Medicine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Innovative Medicine Market, By Therapy Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Small Molecule Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biologic Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- RNA-Based Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Progenitor Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Peptide-Based Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Microbiome Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antisense Oligonucleotide Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- CRISPR-based Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- mRNA-based Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Innovative Medicine Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunology & Inflammation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Regenerative Medicine, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Innovative Medicine Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Innovative Medicine Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Government & Regulatory Bodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Diagnostic labs, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Innovative Medicine Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regeneron Pharmaceuticals Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biogen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
관련자료
